A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway

The emergent Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could produce a maternal immune activation (MIA) via the inflammatory response during gestation that may impair fetal neurodevelopment and lead to postnatal and adulthood menta...

Full description

Bibliographic Details
Main Authors: José Javier Reyes-Lagos, Eric Alonso Abarca-Castro, Juan Carlos Echeverría, Hugo Mendieta-Zerón, Alejandra Vargas-Caraveo, Gustavo Pacheco-López
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Psychology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyg.2021.614451/full
_version_ 1818933750168289280
author José Javier Reyes-Lagos
Eric Alonso Abarca-Castro
Juan Carlos Echeverría
Hugo Mendieta-Zerón
Hugo Mendieta-Zerón
Alejandra Vargas-Caraveo
Gustavo Pacheco-López
author_facet José Javier Reyes-Lagos
Eric Alonso Abarca-Castro
Juan Carlos Echeverría
Hugo Mendieta-Zerón
Hugo Mendieta-Zerón
Alejandra Vargas-Caraveo
Gustavo Pacheco-López
author_sort José Javier Reyes-Lagos
collection DOAJ
description The emergent Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could produce a maternal immune activation (MIA) via the inflammatory response during gestation that may impair fetal neurodevelopment and lead to postnatal and adulthood mental illness and behavioral dysfunctions. However, so far, limited evidence exists regarding long-term physiological, immunological, and neurodevelopmental modifications produced by the SARS-CoV-2 in the human maternal-fetal binomial and, particularly, in the offspring. Relevant findings derived from epidemiological and preclinical models show that a MIA is indeed linked to an increased risk of neurodevelopmental disorders in the offspring. We hypothesize that a gestational infection triggered by SARS-CoV-2 increases the risks leading to neurodevelopmental disorders of the newborn, which can affect childhood and the long-term quality of life. In particular, disruption of either the maternal or the fetal cholinergic anti-inflammatory pathway (CAP) could cause or exacerbate the severity of COVID-19 in the maternal-fetal binomial. From a translational perspective, in this paper, we discuss the possible manifestation of a MIA by SARS-CoV-2 and the subsequent neurodevelopmental disorders considering the role of the fetal-maternal cytokine cross-talk and the CAP. Specifically, we highlight the urgent need of preclinical studies as well as multicenter and international databanks of maternal-fetal psychophysiological data obtained pre-, during, and post-infection by SARS-CoV-2 from pregnant women and their offspring.
first_indexed 2024-12-20T04:53:20Z
format Article
id doaj.art-9120f38f6c984bc9bba02775b55ad702
institution Directory Open Access Journal
issn 1664-1078
language English
last_indexed 2024-12-20T04:53:20Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychology
spelling doaj.art-9120f38f6c984bc9bba02775b55ad7022022-12-21T19:52:48ZengFrontiers Media S.A.Frontiers in Psychology1664-10782021-03-011210.3389/fpsyg.2021.614451614451A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory PathwayJosé Javier Reyes-Lagos0Eric Alonso Abarca-Castro1Juan Carlos Echeverría2Hugo Mendieta-Zerón3Hugo Mendieta-Zerón4Alejandra Vargas-Caraveo5Gustavo Pacheco-López6Faculty of Medicine, Autonomous University of the State of Mexico (UAEMex), Toluca, MexicoMultidisciplinary Research Center in Education (CIME), Autonomous University of the State of Mexico (UAEMex), Toluca, MexicoBasic Sciences and Engineering Division, Campus Iztapalapa, Metropolitan Autonomous University (UAM), Mexico City, MexicoFaculty of Medicine, Autonomous University of the State of Mexico (UAEMex), Toluca, MexicoHealth Institute of the State of Mexico (ISEM), “Mónica Pretelini Sáenz” Maternal-Perinatal Hospital, Toluca, MexicoBiological and Health Sciences Division, Campus Lerma, Metropolitan Autonomous University (UAM), Lerma, MexicoBiological and Health Sciences Division, Campus Lerma, Metropolitan Autonomous University (UAM), Lerma, MexicoThe emergent Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could produce a maternal immune activation (MIA) via the inflammatory response during gestation that may impair fetal neurodevelopment and lead to postnatal and adulthood mental illness and behavioral dysfunctions. However, so far, limited evidence exists regarding long-term physiological, immunological, and neurodevelopmental modifications produced by the SARS-CoV-2 in the human maternal-fetal binomial and, particularly, in the offspring. Relevant findings derived from epidemiological and preclinical models show that a MIA is indeed linked to an increased risk of neurodevelopmental disorders in the offspring. We hypothesize that a gestational infection triggered by SARS-CoV-2 increases the risks leading to neurodevelopmental disorders of the newborn, which can affect childhood and the long-term quality of life. In particular, disruption of either the maternal or the fetal cholinergic anti-inflammatory pathway (CAP) could cause or exacerbate the severity of COVID-19 in the maternal-fetal binomial. From a translational perspective, in this paper, we discuss the possible manifestation of a MIA by SARS-CoV-2 and the subsequent neurodevelopmental disorders considering the role of the fetal-maternal cytokine cross-talk and the CAP. Specifically, we highlight the urgent need of preclinical studies as well as multicenter and international databanks of maternal-fetal psychophysiological data obtained pre-, during, and post-infection by SARS-CoV-2 from pregnant women and their offspring.https://www.frontiersin.org/articles/10.3389/fpsyg.2021.614451/fullcholinergic anti-inflammatory pathwayquality of lifeCOVID-19neurodevelopmental disordershuman developmentheart rate variability
spellingShingle José Javier Reyes-Lagos
Eric Alonso Abarca-Castro
Juan Carlos Echeverría
Hugo Mendieta-Zerón
Hugo Mendieta-Zerón
Alejandra Vargas-Caraveo
Gustavo Pacheco-López
A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
Frontiers in Psychology
cholinergic anti-inflammatory pathway
quality of life
COVID-19
neurodevelopmental disorders
human development
heart rate variability
title A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
title_full A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
title_fullStr A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
title_full_unstemmed A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
title_short A Translational Perspective of Maternal Immune Activation by SARS-CoV-2 on the Potential Prenatal Origin of Neurodevelopmental Disorders: The Role of the Cholinergic Anti-inflammatory Pathway
title_sort translational perspective of maternal immune activation by sars cov 2 on the potential prenatal origin of neurodevelopmental disorders the role of the cholinergic anti inflammatory pathway
topic cholinergic anti-inflammatory pathway
quality of life
COVID-19
neurodevelopmental disorders
human development
heart rate variability
url https://www.frontiersin.org/articles/10.3389/fpsyg.2021.614451/full
work_keys_str_mv AT josejavierreyeslagos atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT ericalonsoabarcacastro atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT juancarlosecheverria atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT hugomendietazeron atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT hugomendietazeron atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT alejandravargascaraveo atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT gustavopachecolopez atranslationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT josejavierreyeslagos translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT ericalonsoabarcacastro translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT juancarlosecheverria translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT hugomendietazeron translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT hugomendietazeron translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT alejandravargascaraveo translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway
AT gustavopachecolopez translationalperspectiveofmaternalimmuneactivationbysarscov2onthepotentialprenataloriginofneurodevelopmentaldisorderstheroleofthecholinergicantiinflammatorypathway